Molecular Testing in HR+/HER2- mBC

 

University of Kansas Cancer Center Post San Antonio Review
Avatar

Post SABCS Review: Q&A and Case Discussion - Gene Expression Test, ET and Local Therapy Patient Selection, PIK3CA Mutation

By University of Kansas Cancer Center Post San Antonio Review FEATURING Priyanka Sharma, Jennifer Klemp, Angela DeMichele, Aleix Prat, Wendy Woodward, Shane Stecklein
By University of Kansas Cancer Center Post San Antonio Review FEATURING Priyanka Sharma, Jennifer Klemp, Angela DeMichele, Aleix Prat, Wendy Woodward, Shane Stecklein
359 views
February 23, 2022
0 Comments
Login to view comments. Click here to Login
Molecular Testing in HR+/HER2- mBC
04:11
Mario Campone

Alpelisib + Fulvestrant for PIK3CAm HR+/HER2- Advanced BC: SOLAR-1 T…

12:54
UCLA Health

Importance of Thoughtful Testing for PIK3CA Mutations in HR+ MBC

Feat. K. McCann
19:43
2020 Best of Breast

Endocrinopathy Management Related to Oncologic Agents: Alpelisib and…

Feat. S. Kurra
41:48
Association of Community Cancer Centers (ACCC)

Oral Agents for Advanced HR+ Breast Cancer

Feat. L. Boehmer, P. Chalasani, E. Dow, T. Smith
21:10
2022 West Oncology Conference

HR+ Breast Cancer: A Paradigm for Precision Oncology

Feat. L. Schwartzberg
26:04
University of Kansas Cancer Center Post San Antonio Review

Integration of Biomarkers to Inform Treatment Decisions in Breast Ca…

Feat. A. Prat
21:35
Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

2022 Cleveland Clinic Updates in Breast Cancer Surgery

Feat. J. Lang
46:01
University of Kansas Cancer Center Post San Antonio Review

Post SABCS Review: Q&A and Case Discussion - Gene Expression Tes…

Feat. P. Sharma, J. Klemp, A. DeMichele, A. Prat, W. Woodward, S. Stecklein
06:32
ASCO 2022 Conference Coverage

ASCO 2022 on Characterization of Alpelisib-Associated Hyperglycemia …

Feat. S. Shen
09:18
ASCO 2022 Conference Coverage

ASCO 2022 Survival Outcomes in Metastatic HR+, HER2- IDC Compared to…

Feat. J. Mouabbi
06:50
ASCO 2022 Conference Coverage

ASCO 2022 on Alpelisib + Continued ET Following Progression on ET in…

Feat. C. Truica
43
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on Alpelisib + Continued ET Following Pr…

Feat. C. Truica
10:12
ASCO 2022 Conference Coverage

ASCO 2022 on FLEX - the 30,000 Breast Cancer Transcriptome Project: …

Feat. C. Ma
52
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on FLEX - the 30,000 Breast Cancer Trans…

Feat. C. Ma
52
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on FLEX - the 30,000 Breast Cancer Trans…

Feat. C. Ma